Exudative Retinal Detachment (ERD) occurs when fluid accumulates beneath the retina, pushing it away from the retinal tissue. Unlike other forms of detachment, ERD is often caused by inflammation and does not usually involve a tear. Understanding this condition is crucial for early diagnosis and effective treatment.
Exudative retinal detachment (ERD) happens when fluid builds up under the retina, the light-sensitive layer at the back of your eye. This fluid causes the retina to separate from the underlying tissue, which is essential for vision. Unlike other types of retinal detachment that have tears or holes, ERD is often caused by inflammation, vascular problems, or other underlying health conditions. Understanding its unique causes, symptoms, and treatments is vital for preserving vision and preventing lasting damage.
This section clarifies the nature of ERD, how it develops, and why it differs from other forms of retinal detachment. A clear grasp of these aspects helps patients recognize risk factors and why swift action matters.
The retina converts light into neural signals that the brain processes into vision. In ERD, abnormal blood vessels or inflammation cause protein-rich fluid to escape into the potential space beneath the retina. This fluid accumulation physically pushes the retina away from the underlying choroid, often without a retinal tear. The buildup may be diffuse or localized, disrupting normal light reception and causing vision blurring or distortion.
Most retinal detachments are rhegmatogenous, meaning they start with a tear that allows fluid from the vitreous gel to enter beneath the retina. In contrast, ERD is exudative, meaning the fluid originates from blood vessels or tissue inflammation without a tear. Another type, tractional detachment, happens when scar tissue pulls on the retina. Recognizing these differences is crucial for proper diagnosis and management, as the treatment for ERD is focused on addressing the underlying cause of the fluid leak.
People with certain health conditions, such as high blood pressure, autoimmune diseases, or inflammatory eye conditions, are at increased risk of ERD. It may also occur in those with cancers that spread to the eye. While it can happen at any age, it is more common in adults and in patients with existing systemic or eye health problems. Exudative retinal detachments are far less common than rhegmatogenous detachments, accounting for a small fraction of all cases.
ERD caused by systemic diseases, such as autoimmune or inflammatory conditions, may affect both eyes, though it often begins in one. When both eyes are involved, the underlying illness is usually widespread, and treatment may require managing the systemic disease, not just the eye condition. Doctors monitor both eyes carefully during and after treatment to protect vision.
ERD arises from various medical conditions that disrupt the normal fluid balance in the subretinal space. Recognizing these causes is the first step toward effective treatment and vision preservation.
Chronic or acute inflammation in the eye—such as uveitis, Vogt-Koyanagi-Harada disease, or sarcoidosis—can trigger fluid leakage and ERD. These conditions often require systemic immunosuppression alongside ocular treatment to control activity and prevent recurrence. The retina may become swollen, which further impairs vision and can be visible on examination.
Diseases affecting the eye’s blood vessels, including central serous chorioretinopathy (CSC), retinal angiomatous proliferation, or hypertensive retinopathy, can precipitate ERD. In CSC, localized fluid leakage causes a serous detachment, while in hypertensive cases, vascular damage leads to broader leakage. Managing the underlying vascular issue is often key to resolving the detachment.
Tumors, especially choroidal melanoma or metastatic cancers that spread to the eye, can induce ERD by directly disrupting retinal architecture or altering local vasculature. In rare cases, paraneoplastic syndromes associated with remote cancers may also cause widespread inflammation and leakage in the eye. Prompt identification of cancer-related ERD is critical for both eye and general health.
Some medications, including certain cancer therapies, steroids, and immune-modulating drugs, can affect the blood-retinal barrier and lead to ERD. Post-surgical changes, such as after glaucoma drainage device implantation, can also cause fluid accumulation. A thorough medication review is important when evaluating unexplained fluid buildup.
Severe intraocular infections, such as toxoplasmosis or cytomegalovirus retinitis, can cause both inflammation and direct tissue destruction, resulting in ERD. In some cases, ERD occurs as a late complication after the acute infection has been treated. Specialized testing may be needed to identify infectious causes.
Symptoms of ERD can be subtle or dramatic, often depending on the extent and location of fluid buildup. Early recognition is vital for prompt and effective intervention.
Many patients first notice a gradual loss of visual clarity, often described as looking through rippled glass or water. The degree of blurring may fluctuate, worsening with activity or systemic illness. Sometimes, the onset is sudden, especially if caused by acute inflammation or vascular events.
Detachment in the central retina (macula) causes the most noticeable vision loss, while peripheral involvement may be subtler. Patients may notice dimming, shadows, or missing areas in their field of vision. Central distortions make reading and recognizing faces difficult.
Floaters—spots or cobweb-like shapes—may increase, especially if vitreous changes occur alongside ERD. Flashing lights (photopsias) are less common but can be present, particularly if inflammation affects the vitreous. The symptoms of ERD are typically painless.
If you notice any sudden changes in your vision, contact an eye care professional immediately. Delaying evaluation can result in permanent damage, but quick treatment often improves outcomes. Even small changes matter since ERD can worsen quickly. Regular eye checkups remain the best way to detect problems early.
Accurate diagnosis of ERD requires a combination of clinical examination and specialized imaging. These steps help distinguish ERD from other retinal conditions and identify the underlying cause.
A dilated fundus examination by an ophthalmologist is the cornerstone of diagnosis, allowing direct visualization of the retina and any fluid underneath. Your pupils will be dilated with eye drops so the doctor can see the back of your eye clearly. The exam is painless and helps spot fluid buildup, swelling, or detachment.
Optical coherence tomography (OCT) is the gold standard for identifying and monitoring subretinal fluid. OCT can show the precise layers involved, the extent of detachment, and sometimes clues to the cause. Fundus autofluorescence imaging can help distinguish chronic from acute fluid, while fluorescein angiography highlights leaking blood vessels.
B-scan ultrasound is used when media opacities (e.g., cataract, vitreous hemorrhage) prevent a clear retinal view, and it is particularly helpful for detecting tumors. In some cases, blood tests or systemic imaging may be needed to identify autoimmune or neoplastic causes. Your eye doctor needs to know about all your health conditions and medicines to understand your risk.
Treatment of ERD is tailored to the underlying cause, with the goal of reducing fluid accumulation, reattaching the retina, and preserving vision. Most patients benefit from a combination of medical and, in some cases, surgical interventions.
Steroids—delivered by eye drops, periocular injection, or orally—are the mainstay for inflammation-driven ERD. Immune-modulating drugs may be used for autoimmune cases. For vascular causes, anti-VEGF injections (such as aflibercept or ranibizumab) target leaky blood vessels and can be highly effective. Systemic medications may also be needed to control underlying disease.
Laser photocoagulation uses focused light to seal leaking blood vessels and stop further fluid buildup. This outpatient procedure is quick and usually has minimal discomfort. Photodynamic therapy (PDT) uses a light-sensitive drug to selectively close abnormal vessels. These outpatient procedures are generally well tolerated, with minimal recovery time.
More serious cases may need surgery to drain the fluid and help the retina reattach. A vitrectomy removes the gel inside your eye and allows direct access to drain subretinal fluid. Sometimes a scleral buckle, which is like a belt placed around your eye, provides extra support. These procedures are done with anesthesia to keep you comfortable.
If you're experiencing changes in your vision or have concerns about Exudative Retinal Detachment, don't wait. Contact a top optometrist or ophthalmologist listed with Specialty Vision today to get the care you need. Protect your vision and health with expert guidance tailored to your needs.
If you notice vision changes or have risk factors for ERD, seek prompt evaluation by an eye care specialist. Early diagnosis and tailored treatment offer the best chance for preserving sight. Our retina team is committed to providing comprehensive, compassionate care and guiding you through every phase of management. Protecting your vision starts with awareness and proactive care—schedule your eye exam today.
If you're experiencing changes in your vision or have concerns about Exudative Retinal Detachment, don't wait. Contact a top optometrist or ophthalmologist listed with Specialty Vision today to get the care you need. Protect your vision and health with expert guidance tailored to your needs.
Exudative Retinal Detachment (ERD) leads to vision issues as fluid builds up under the retina. Learn about its symptoms, causes, and treatments.
